Anaplastic Multiple Myeloma: A Report of a Rare Case with CD38 and CD117 Positivity
PDF
Cite
Share
Request
Case report
P: 272-276
2023

Anaplastic Multiple Myeloma: A Report of a Rare Case with CD38 and CD117 Positivity

Acta Haematol Oncol Turc 2023;56(3):272-276
1. Selcuk University Faculty Of Medicine, Department Of Hematology, Konya, Turkey
2. Department Of Nuclear Medicine, Konya City Hospital, Konya, Turkey
3. Department Of Pediatric Immunology, Necmettin Erbakan University, Faculty Of Medicine, Konya, Turkey
4.
No information available.
No information available
Received Date: 2023-02-07T21:34:50
Accepted Date: 2023-12-04T07:28:49
PDF
Cite
Share
Request

Abstract

Anaplastic multiple myeloma (AMM), which comprises anaplastic multiple myeloma and anaplastic plasmacytoma, is a rare illness that aggressively advances as a morphological subtype of multiple myeloma (MM). It has a poor prognosis and is believed to be particularly resistant to treatment. In this case report, we presented a 66-year-old woman diagnosed with AMM. The anaplastic morphology of MM may pose a diagnostic challenge. The need for a multidisciplinary approach to detect hematological neoplasms is highlighted in this example. For AMM instances, prompt radiographic, flowcytometry, and histological examination may assist guide effective treatment strategies.